Concretely: a 27G needle · 8 mg/mL.
I want the working, not the result — I need to be able to redo it with different numbers.
I care about the precision as well as the value — I want to know how many figures are real.
Is my approach right even if my number is wrong?
At 8 mg/mL every microlitre left behind is 8 µg, so a 50 µL hub costs 0.4 mg per draw and a 5 µL fixed-needle barrel costs 0.04 mg. Multiply by the draws, not by the doses: ten draws through a 50 µL dead space is 4 mg gone, which at 8 mg/mL is 0.5 mL of solution you paid for and never administered. Against a 2 mg dose that 50 µL is 20 per cent; against a 0.25 mg dose it is 160 per cent, which is why the loss matters most at exactly the doses where you can least afford it. a 27G needle has a bore, a hub and a length, and the hub dominates: a fixed-needle insulin barrel has almost none, a luer connection has a measurable one before the needle even starts.
Start from the worked arithmetic: a 10 mg vial reconstituted with 2 mL gives 5 mg/mL. One hundred microliter draws are 0.5 mg each. At 84 µL dead space per draw, half your vial disappears into the hub.
The needle lumen volume is under a microlitre in a typical fine-gauge configuration, so the needle is not the problem.
Configuration A — 1 mL luer-lock plus detachable needle, dead space 84 µL: each draw removes 100 + 84 = 184 µL. Draws available from 2,000 µL = 2000 / 184 = 10.87, so 10 full draws.
The World Health Organisation guidance on injection equipment adopted the same high-versus-low dead-space distinction, using a low-dead-space threshold in the low single-digit microlitres.
The switch nearly doubles your vial, which is better than most other optimisations combined.
HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.
Submit a sampleFounded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.
Visit GL BiochemA fixed-needle insulin syringe holds roughly 3 to 5 µL dead space and costs the same as a luer-lock syringe with 35 to 100 µL dead space.
Delivered peptide = 10 x 0.5 mg = 5.0 mg. Lost to dead space = 10 x 84 µL = 840 µL x 0.005 = 4.2 mg. Yield = 50 per cent.
The complete rule: fix the syringe architecture first, and then the reconstitution volume becomes a free choice you can make on stability grounds rather than on economics.
I would not underestimate the dead-space cost when calculating your true cost per dose.
Buy the right syringe — a fixed-needle insulin syringe is cheap and solves the problem.
The single most important fact about dead space is that it is almost entirely in the hub cone, not in the needle, which is why changing needle gauge or length barely changes your losses.
Low-dead-space syringe designs either have the needle bonded directly to the barrel — a fixed-needle syringe, which is the cheapest route — or add a moulded projection on the plunger tip that fills the luer cone.
It helps to be literal here: the luer cone of the syringe plus the needle's own plastic hub accounts for the vast majority of the dead space.
Worth noting: draw size matters enormously — the smaller your draws, the more the syringe architecture matters.
If cost matters, this is the first thing to change, not the last.
Before anything else: understand that dead space is a property of the syringe architecture, not of the needle gauge.
At 5 mg/mL that is 15 to 25 µg lost per draw on the insulin syringe and 175 to 500 µg on the luer-lock — which over ten draws is the difference between losing a rounding error and losing half a milligram.
Syringe residual volume has been measured properly, mainly in the infection-control literature, with a median residual of about 84 µL for a conventional 1 mL syringe with a detachable needle and roughly 2 µL for a fixed-needle low-dead-space design.
Write the arithmetic on the vial label. It costs nothing and it removes the step where you reconstruct it from memory at an inconvenient moment.
edited 18 Jul 2025 by thabo_maseko — updated for the 2026 guidance change
The short answer is that dead space is small in absolute terms and huge as a fraction of a small dose, which is why it feels like a rounding error and behaves like a systematic loss.
Dead space quantified: a fixed-needle insulin syringe holds roughly 3 to 5 µL in the hub and needle after the plunger bottoms out. A luer-lock syringe with a detachable needle holds 35 to 100 µL depending on the hub design.
Published inter-laboratory comparisons of dead-space measurements on identical syringes show good agreement, suggesting the numbers are reliable.
The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing, and check the syringe scale against the barrel rather than against your assumption.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.